Smartwatch could replace cuff for blood pressure checks

NCT ID NCT06508619

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether the Corsano CardioWatch 287-2, a smartwatch that measures blood pressure using light sensors, can accurately track blood pressure changes in people starting or adjusting their blood pressure medication. Eighty adults with uncontrolled high blood pressure wore the watch for 28 days while also using a standard arm cuff for comparison. The goal was to see if the watch could reliably measure the drop in blood pressure after treatment changes, potentially enabling remote monitoring at home.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Corsano CardioWatch 287-2 (a smartwatch that measures blood pressure using light sensors)
What this could lead to
If successful, this could show that a smartwatch can reliably monitor blood pressure at home, potentially reducing the need for frequent clinic visits.
What could go wrong
This is a small, completed study (80 people) that only checks accuracy over 28 days. The device may not be as precise as a standard cuff, and results may not apply to all patients or long-term use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH BLOOD PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Reinier de Graaf Gasthuis

    Delft, South Holland, 2625 AD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.